Level Biotechnology (3118) — Capital Reinvestment Ratio
Level Biotechnology (3118) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$11.81 Million) in capital expenditures (NT$4.44 Million). Check how tangible is Level Biotechnology's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Level Biotechnology Capital Reinvestment Ratio (2017–2024)
This chart tracks Level Biotechnology's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Level Biotechnology generate cash.
Annual Capital Reinvestment Ratio for Level Biotechnology (2017–2024)
Year-by-year Capital Reinvestment Ratio for Level Biotechnology from 2017 to 2024. See how much free cash does Level Biotechnology generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.49x | NT$64.10 Million | NT$223.68 Million | ▲ +3095.2% |
| 2023 | 0.11x | NT$70.21 Million | NT$7.67 Million | ▲ +5.5% |
| 2022 | 0.10x | NT$65.07 Million | NT$6.74 Million | ▲ +76.4% |
| 2021 | 0.06x | NT$155.95 Million | NT$9.15 Million | ▲ +92.3% |
| 2020 | 0.03x | NT$83.23 Million | NT$2.54 Million | ▲ +37.2% |
| 2019 | 0.02x | NT$109.02 Million | NT$2.43 Million | ▼ -76.3% |
| 2018 | 0.09x | NT$26.77 Million | NT$2.51 Million | ▼ -38.2% |
| 2017 | 0.15x | NT$71.29 Million | NT$10.83 Million | — |